UNSPSC 51262600: Adrenergic blocking agent imidazoles

This classification denotes adrenergic blocking agents made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.

UNSPSC 51262600 Adrenergic blocking agent imidazoles is a Class code that in recent state and local procurement activity covers the supply of naloxone and related emergency pharmaceutical products to public health agencies. The code's nominal chemical definition does not align with the actual scope of work being solicited; recent opportunities show state and local procurement offices buying naloxone and drug deactivation systems for community health and emergency response, not the narrower imidazole-class pharmaceuticals the code name suggests. Issuing bodies include county health departments and state health and human services agencies. Seminole County, Florida released an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a July 26, 2023 response deadline and a two-year initial contract term plus one-year renewal option. Texas Health and Human Services Commission issued a Request for Information in April 2026 to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program, signaling broader state interest in direct pharmaceutical supply relationships beyond traditional pharmacy benefit manager channels.

Recent activity centers on Florida and Texas, with the Seminole County opportunity emphasizing volume commodity procurement of emergency pharmaceuticals with quarterly distribution cycles and the Texas HHS RFI representing early-stage exploratory procurement to reshape the state's pharmacy benefit and prescription fulfillment model. The Seminole County IFB specifies fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and potential FEMA funding with corresponding federal compliance requirements. Neither opportunity carries explicit set-aside designations. The mismatch between the UNSPSC code's chemical name and actual procurement scope suggests this code may not be the primary taxonomy state and local offices use for naloxone and emergency pharmaceutical procurement; businesses tracking this category should monitor whether jurisdictions migrate these opportunities to a broader pharmaceutical-supply or emergency-response code over time.